These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11569183)
21. [Topical H1 antihistaminics in the therapy of acute conjunctival allergic reactions]. Haicl P; Cerná H Cesk Slov Oftalmol; 2004 Jan; 60(1):58-63. PubMed ID: 15011308 [TBL] [Abstract][Full Text] [Related]
22. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children]. Endre L Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028 [TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of steroid nasal spray versus antihistamine nasal spray in allergic rhinitis. Ghimire A; Das BP; Mishra SC Nepal Med Coll J; 2007 Mar; 9(1):17-21. PubMed ID: 17593672 [TBL] [Abstract][Full Text] [Related]
24. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis]. Endre L; Hidasi V Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Leonardi A; Zafirakis P Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370 [TBL] [Abstract][Full Text] [Related]
27. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis. Ilyas H; Slonim CB; Braswell GR; Favetta JR; Schulman M Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462 [TBL] [Abstract][Full Text] [Related]
28. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy]. Nicoară S Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108 [TBL] [Abstract][Full Text] [Related]
30. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital. Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases]. Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339 [TBL] [Abstract][Full Text] [Related]
32. [Effectiveness and impact in the quality of life of ketotifen ophthalmic solution. Results of zeta study in patients with seasonal allergic conjunctivitis]. Lloves J; Montero Iruzubieta J; Sainz De La Maza Serra MT; Fuster Jensen E; Lladonosa Montull A Arch Soc Esp Oftalmol; 2003 Aug; 78(8):433-41. PubMed ID: 12955623 [TBL] [Abstract][Full Text] [Related]
33. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786 [TBL] [Abstract][Full Text] [Related]
34. [A comparative study of the ocular tolerance after administration of anti-allergic eye drops with or without a preservative]. Beden C; Helleboid L; Marmouz F; Liard F Therapie; 2004; 59(2):259-64. PubMed ID: 15359624 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of conjunctivitis]. Barabási Z Orv Hetil; 2004 Oct; 145(41):2107-10. PubMed ID: 15586586 [No Abstract] [Full Text] [Related]
36. Effect of azelastine nasal spray on histamine-and allergen-induced skin wheal response in patients with allergic rhinitis. Agarwal MK; Vijayan VK; Vermani M J Asthma; 2008 Sep; 45(7):548-51. PubMed ID: 18773324 [TBL] [Abstract][Full Text] [Related]
37. [Therapy of chronic allergic conjunctivitis with sodium cromoglycate (lecrolin)]. Polunin GS; Makarov IA Vestn Oftalmol; 1997; 113(2):21-2. PubMed ID: 9229898 [TBL] [Abstract][Full Text] [Related]
38. [Misleading advertisement on Opatanol]. Timmermans AE Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1472. PubMed ID: 16875272 [TBL] [Abstract][Full Text] [Related]
39. [Allergic ocular diseases; from mechanisms through treatments]. Fukagawa K Arerugi; 2004 Jan; 53(1):8-13. PubMed ID: 14762325 [No Abstract] [Full Text] [Related]
40. Time to manage seasonal ocular allergies. Smith SE J Ophthalmic Nurs Technol; 2000; 19(2):68-73. PubMed ID: 11075076 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]